Eric Hurel

Head Of HR Us, Europe And Emerging Markets at EUSA Pharma

Eric Hurel has extensive experience in the pharmaceutical industry, particularly in human resources management. Eric is currently the Human Resources Director Industrial Operations at Recordati-Eusapharma, where they oversee HR operations for pharmaceutical and chemical plants in multiple countries. Prior to this role, they served as the Head of HR for US, Europe, and Emerging Markets at EUSA Pharma. Eric also held various senior HR positions at ACTELION PHARMACEUTICALS, GALDERMA, and SERVIER DO BRASIL, where they had responsibilities in HR strategy, talent management, and the establishment of new affiliates in different regions. Overall, Eric Hurel's work experience showcases their expertise in HR leadership and their international exposure in the pharmaceutical industry.

Eric Hurel received an MBA in International Business from Esade between 1988 and 1990. Prior to that, they obtained a Master Degree in Business Law from Université Paris Nanterre from 1983 to 1988. Eric completed their high school education at Lycée St Erembert-Saint Germain en Laye from 1979 to 1983, and their secondary school education at Lycée Jean Mermoz-Buenos Aires from 1975 to 1978. Eric began their academic journey at alliance franco argentina where they completed their primary school education until 1975. Eric Hurel also obtained certifications in Mediation from Ifomen in 2020 and in Coaching from Alter Coach in 2009.

Location

Paris, France

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


EUSA Pharma

1 followers

We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.